Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 223

1.

Prognostic role of p53 messenger ribonucleic acid expression in patients after curative resection for stage I to III colorectal cancer: association with colon cancer stem cell markers.

Huh JW, Kim HR, Kim YJ.

J Am Coll Surg. 2013 Jun;216(6):1063-9. doi: 10.1016/j.jamcollsurg.2013.01.058. Epub 2013 Apr 6.

PMID:
23571142
2.

Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.

Uen YH, Lin SR, Wu DC, Su YC, Wu JY, Cheng TL, Chi CW, Wang JY.

Ann Surg. 2007 Dec;246(6):1040-6.

PMID:
18043108
3.

Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.

Hirai K, Koizumi K, Haraguchi S, Hirata T, Mikami I, Fukushima M, Yamagishi S, Kawashima T, Okada D, Shimizu K, Kawamoto M.

Ann Thorac Surg. 2005 Jan;79(1):248-53.

PMID:
15620951
4.

Clinical significance of BMP7 in human colorectal cancer.

Motoyama K, Tanaka F, Kosaka Y, Mimori K, Uetake H, Inoue H, Sugihara K, Mori M.

Ann Surg Oncol. 2008 May;15(5):1530-7. doi: 10.1245/s10434-007-9746-4. Epub 2008 Feb 8.

PMID:
18259822
5.

P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.

Theodoropoulos GE, Karafoka E, Papailiou JG, Stamopoulos P, Zambirinis CP, Bramis K, Panoussopoulos SG, Leandros E, Bramis J.

Anticancer Res. 2009 Feb;29(2):785-91.

6.

Pretreatment expression of 13 molecular markers as a predictor of tumor responses after neoadjuvant chemoradiation in rectal cancer.

Huh JW, Lee JH, Kim HR.

Ann Surg. 2014 Mar;259(3):508-15. doi: 10.1097/SLA.0b013e31829b3916.

PMID:
23787217
7.

Expression of annexin a5 is associated with higher tumor stage and poor prognosis in colorectal adenocarcinomas.

Xue G, Hao LQ, Ding FX, Mei Q, Huang JJ, Fu CG, Yan HL, Sun SH.

J Clin Gastroenterol. 2009 Oct;43(9):831-7. doi: 10.1097/MCG.0b013e31819cc731.

PMID:
19461527
8.

Laparoscopy as a prognostic factor in curative resection for node positive colorectal cancer: results for a single-institution nonrandomized prospective trial.

Capussotti L, Massucco P, Muratore A, Amisano M, Bima C, Zorzi D.

Surg Endosc. 2004 Jul;18(7):1130-5. Epub 2004 May 27.

PMID:
15156384
9.

Prognostic significance of MMP-1 and MMP-3 functional promoter polymorphisms in colorectal cancer.

Zinzindohoué F, Lecomte T, Ferraz JM, Houllier AM, Cugnenc PH, Berger A, Blons H, Laurent-Puig P.

Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):594-9.

10.
11.

Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer.

Wang X, Wang J, Ma H, Zhang J, Zhou X.

Med Oncol. 2012 Jun;29(2):919-27. doi: 10.1007/s12032-011-9880-5. Epub 2011 Mar 10.

PMID:
21390519
12.

Prognostic value of putative circulating cancer stem cells in patients undergoing hepatic resection for colorectal liver metastasis.

Pilati P, Mocellin S, Bertazza L, Galdi F, Briarava M, Mammano E, Tessari E, Zavagno G, Nitti D.

Ann Surg Oncol. 2012 Feb;19(2):402-8. doi: 10.1245/s10434-011-2132-2. Epub 2011 Nov 10.

PMID:
22071867
13.

Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.

Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.

BMC Cancer. 2007 Apr 12;7:63.

14.

Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma.

Giatromanolaki A, Stathopoulos GP, Tsiompanou E, Papadimitriou C, Georgoulias V, Gatter KC, Harris AL, Koukourakis MI.

Cancer. 1999 Oct 15;86(8):1421-30. Erratum in: Cancer. 2009 Sept 1;115(17):4040. Tsiobanou, E [corrected to Tsiompanou, E].

PMID:
10526268
15.

Detection of carcinoembryonic antigen messenger RNA-expressing cells in peripheral blood 7 days after curative surgery is a novel prognostic factor in colorectal cancer.

Sadahiro S, Suzuki T, Maeda Y, Yurimoto S, Yasuda S, Makuuchi H, Kamijo A, Murayama C.

Ann Surg Oncol. 2007 Mar;14(3):1092-8. Epub 2007 Jan 3.

PMID:
17200912
16.

Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer.

Guller U, Zajac P, Schnider A, Bösch B, Vorburger S, Zuber M, Spagnoli GC, Oertli D, Maurer R, Metzger U, Harder F, Heberer M, Marti WR.

Ann Surg. 2002 Dec;236(6):768-75; discussion 775-6.

17.
18.
19.

Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.

Iinuma H, Watanabe T, Mimori K, Adachi M, Hayashi N, Tamura J, Matsuda K, Fukushima R, Okinaga K, Sasako M, Mori M.

J Clin Oncol. 2011 Apr 20;29(12):1547-55. doi: 10.1200/JCO.2010.30.5151. Epub 2011 Mar 21.

PMID:
21422427
20.

Prognostic significance of immunohistochemically localized biomarkers in stage II and stage III breast cancer: a multivariate analysis.

Bhatavdekar JM, Patel DD, Shah NG, Vora HH, Suthar TP, Chikhlikar PR, Ghosh N, Trivedi TI.

Ann Surg Oncol. 2000 May;7(4):305-11.

PMID:
10819372

Supplemental Content

Support Center